
Suzanne Marie Noakes
Examiner (ID: 17824)
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1691 |
| Issued Applications | 1090 |
| Pending Applications | 193 |
| Abandoned Applications | 452 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19091172
[patent_doc_number] => 11952604
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Enzymatic method for preparing Rebaudioside J
[patent_app_type] => utility
[patent_app_number] => 17/805626
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2177
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17805626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/805626 | Enzymatic method for preparing Rebaudioside J | Jun 5, 2022 | Issued |
Array
(
[id] => 17867381
[patent_doc_number] => 20220290117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => ENZYMATIC PRODUCTION OF HEXOSES
[patent_app_type] => utility
[patent_app_number] => 17/825484
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17825484
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/825484 | Enzymatic production of hexoses | May 25, 2022 | Issued |
Array
(
[id] => 18537789
[patent_doc_number] => 20230242889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => RECOMBINASE POLYMERASE AMPLIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/750758
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/750758 | Recombinase polymerase amplification | May 22, 2022 | Issued |
Array
(
[id] => 17871253
[patent_doc_number] => 20220293990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => ELECTRON CARRIER, ELECTRON CARRIER PRODUCTION METHOD, AND ELECTRON TRANSFER METHOD
[patent_app_type] => utility
[patent_app_number] => 17/748678
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748678
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/748678 | ELECTRON CARRIER, ELECTRON CARRIER PRODUCTION METHOD, AND ELECTRON TRANSFER METHOD | May 18, 2022 | Pending |
Array
(
[id] => 18093529
[patent_doc_number] => 20220411870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => Treatment Of Obesity With G-Protein Coupled Receptor 75 (GPR75) Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/748110
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 127953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/748110 | Treatment Of Obesity With G-Protein Coupled Receptor 75 (GPR75) Inhibitors | May 18, 2022 | Pending |
Array
(
[id] => 18093529
[patent_doc_number] => 20220411870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => Treatment Of Obesity With G-Protein Coupled Receptor 75 (GPR75) Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/748110
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 127953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/748110 | Treatment Of Obesity With G-Protein Coupled Receptor 75 (GPR75) Inhibitors | May 18, 2022 | Pending |
Array
(
[id] => 17837728
[patent_doc_number] => 20220275033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => MODIFIED CYANOBACTERIUM, MODIFIED CYANOBACTERIUM PRODUCTION METHOD, AND PROTEIN PRODUCTION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/747607
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747607
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/747607 | MODIFIED CYANOBACTERIUM, MODIFIED CYANOBACTERIUM PRODUCTION METHOD, AND PROTEIN PRODUCTION METHOD | May 17, 2022 | Pending |
Array
(
[id] => 18295918
[patent_doc_number] => 20230105604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => COMPOSITION INCLUDING I2SCN- IONS AND/OR I(SCN)2- IONS
[patent_app_type] => utility
[patent_app_number] => 17/747572
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747572
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/747572 | COMPOSITION INCLUDING I2SCN- IONS AND/OR I(SCN)2- IONS | May 17, 2022 | Abandoned |
Array
(
[id] => 17837728
[patent_doc_number] => 20220275033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => MODIFIED CYANOBACTERIUM, MODIFIED CYANOBACTERIUM PRODUCTION METHOD, AND PROTEIN PRODUCTION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/747607
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747607
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/747607 | MODIFIED CYANOBACTERIUM, MODIFIED CYANOBACTERIUM PRODUCTION METHOD, AND PROTEIN PRODUCTION METHOD | May 17, 2022 | Pending |
Array
(
[id] => 19862585
[patent_doc_number] => 20250101371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => MICROBIAL STRAIN EXPRESSING AN INVERTASE/SUCROSE HYDROLASE
[patent_app_type] => utility
[patent_app_number] => 18/561246
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561246
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561246 | MICROBIAL STRAIN EXPRESSING AN INVERTASE/SUCROSE HYDROLASE | May 16, 2022 | Pending |
Array
(
[id] => 18406119
[patent_doc_number] => 20230167470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => METHOD AND STRAINS FOR REDUCING BYPRODUCT SUCCINIC ACID IN FERMENTATION PROCESS OF L-MALIC ACID AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/744778
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744778
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744778 | Method and strains for reducing byproduct succinic acid in fermentation process of L-malic acid and use thereof | May 15, 2022 | Issued |
Array
(
[id] => 17830443
[patent_doc_number] => 20220267747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells
[patent_app_type] => utility
[patent_app_number] => 17/741326
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 331
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17741326
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/741326 | Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells | May 9, 2022 | Abandoned |
Array
(
[id] => 19521333
[patent_doc_number] => 12123045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-22
[patent_title] => Genetically modified cells that produce C6-C10 fatty acid derivatives
[patent_app_type] => utility
[patent_app_number] => 17/661613
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31522
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17661613
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/661613 | Genetically modified cells that produce C6-C10 fatty acid derivatives | May 1, 2022 | Issued |
Array
(
[id] => 17807744
[patent_doc_number] => 20220259579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES
[patent_app_type] => utility
[patent_app_number] => 17/732927
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -138
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17732927
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/732927 | ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES | Apr 28, 2022 | Abandoned |
Array
(
[id] => 17946136
[patent_doc_number] => 20220333153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => ULTRASENSITIVE ELECTROCHEMICAL BIOSENSORS
[patent_app_type] => utility
[patent_app_number] => 17/732296
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16294
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17732296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/732296 | ULTRASENSITIVE ELECTROCHEMICAL BIOSENSORS | Apr 27, 2022 | Abandoned |
Array
(
[id] => 17792531
[patent_doc_number] => 20220251622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => Method for Producing Protein
[patent_app_type] => utility
[patent_app_number] => 17/730750
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730750 | Method for Producing Protein | Apr 26, 2022 | Pending |
Array
(
[id] => 18020952
[patent_doc_number] => 20220372451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => PRODUCTION OF PYRUVATE OR PRODUCTS DERIVED FROM PYRUVATE USING MODIFIED ESCHERICHIA COLI
[patent_app_type] => utility
[patent_app_number] => 17/729120
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17729120
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/729120 | PRODUCTION OF PYRUVATE OR PRODUCTS DERIVED FROM PYRUVATE USING MODIFIED ESCHERICHIA COLI | Apr 25, 2022 | Abandoned |
Array
(
[id] => 19650054
[patent_doc_number] => 12171814
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Protein complex including botulinum toxin translocation domain and endolysin and antibacterial composition including same
[patent_app_type] => utility
[patent_app_number] => 18/287223
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 26
[patent_no_of_words] => 9097
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287223
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287223 | Protein complex including botulinum toxin translocation domain and endolysin and antibacterial composition including same | Apr 17, 2022 | Issued |
Array
(
[id] => 18620633
[patent_doc_number] => 11753661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Process for the biological production of methacrylic acid and derivatives thereof
[patent_app_type] => utility
[patent_app_number] => 17/720739
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 29
[patent_no_of_words] => 24807
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17720739
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/720739 | Process for the biological production of methacrylic acid and derivatives thereof | Apr 13, 2022 | Issued |
Array
(
[id] => 17897335
[patent_doc_number] => 20220306997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => GENETIC ENGINEERING OF FUNGI TO MODULATE TRYPTAMINE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/711270
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/711270 | GENETIC ENGINEERING OF FUNGI TO MODULATE TRYPTAMINE EXPRESSION | Mar 31, 2022 | Pending |